<html>
<head>
<title>Utah Legislature HB0375</title>
</head>
<body>
<div id="content">
<font face="Arial">
</font><font face="Arial" size="3">1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>PRESCRIPTION DRUG ABUSE AMENDMENTS</b></font><font face="Arial" size="2"></center><br/>2&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>2016 GENERAL SESSION</center><br/>3&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center>STATE OF UTAH</center><br/>4&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3"><b>Chief Sponsor:  LaVar Christensen</b></font><font face="Arial" size="2"></center><br/>5&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center></font><font face="Arial" size="3">Senate Sponsor:  </font><font face="Arial" size="2"></font><font face="Arial" size="3">____________</font><font face="Arial" size="2"></center><br/>6&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>7&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>LONG TITLE</b><br/>8&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>General Description:</b><br/>9&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill requires prescribers and dispensers to use the controlled substance database<br/>10&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;before prescribing or dispensing an opioid to determine whether a patient may be<br/>11&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;abusing prescription medication.<br/>12&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Highlighted Provisions:</b><br/>13&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This bill:<br/>14&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;defines terms;<br/>15&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;amends the Controlled Substances Database Act to add requirements for prescribers<br/>16&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and dispensers to use the controlled substance database before prescribing or<br/>17&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;dispensing an opioid;<br/>18&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;requires a dispenser to consult with the prescriber if the controlled substance<br/>19&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;database suggests potential prescription drug abuse; and<br/>20&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#9656;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;makes technical changes.<br/>21&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Money Appropriated in this Bill:</b><br/>22&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>23&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Other Special Clauses:</b><br/>24&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None<br/>25&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>Utah Code Sections Affected:</b><br/>26&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;ENACTS:<br/>27&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<a href="#58-37f-303">58-37f-303</a></b>, Utah Code Annotated 1953<br/><hr>28&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <hr style="width:90%; padding: 0; border: none; border-top: thick double #333; color: #333; text-align: right" /><br/>29&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<i>Be it enacted by the Legislature of the state of Utah:</i><br/>30&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.  Section <b>58-37f-303</b><a name="58-37f-303"></a> is enacted to read:<br/>31&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<center><b>Part 3.  Access and Utilization</b></center><br/>32&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<b><u>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;58-37f-303.</u></b>  <b>Database utilization.</b><br/>33&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(1)  As used in this section:</u><br/>34&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  "Dispenser" means a licensed pharmacist, as described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-303&session=2016GS">58-17b-303</a>, or</u><br/>35&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>the pharmacist's licensed intern, as described in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-17b-304&session=2016GS">58-17b-304</a>, who is also licensed to</u><br/>36&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>dispense a controlled substance under Title 58, Chapter 37, Utah Controlled Substances Act.</u><br/>37&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  "Hospice" means the same as that term is defined in Section <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=26-21-2&session=2016GS">26-21-2</a>.</u><br/>38&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(c)  "Opioid" means those substances listed in Subsection <a href="http://le.utah.gov/UtahCode/SectionLookup.jsp?section=58-37-4&session=2016GS">58-37-4</a>(2)(b)(i) or (2)(b)(ii).</u><br/>39&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(d)  "Prescriber" means an individual authorized to prescribe a controlled substance</u><br/>40&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>under Title 58, Chapter 37, Utah Controlled Substances Act.</u><br/>41&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(e)  "Terminal illness" means a condition of a patient that is medically confirmed to</u><br/>42&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>lead to the patient's imminent death.</u><br/>43&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)  To address the serious concern of life-altering and life-threatening opioid abuse and</u><br/>44&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>overdose, and to achieve the purposes and maximize the benefits of the carefully developed</u><br/>45&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>and highly respected database:</u><br/>46&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(a)  except as provided in Subsection (4)(a), a prescriber shall access and review the</u><br/>47&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>database, in accordance with Subsection (3)(a), at the following times:</u><br/>48&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  before writing a prescription for an opioid;</u><br/>49&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  at least once every three months for a patient whose prescribed or foreseeable</u><br/>50&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>opioid treatment extends beyond three months; or</u><br/>51&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  at any time when the prescriber, in the prescriber's professional judgment, has a</u><br/>52&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>reasonable suspicion that a patient:</u><br/>53&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(A)  is or may be attempting to obtain a medically unnecessary opioid or quantity of an</u><br/>54&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>opioid; or</u><br/>55&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(B)  exhibits potential for abuse or misuse of an opioid; and</u><br/>56&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  except as provided in Subsection (4)(b), a dispenser shall access and review the</u><br/>57&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>database in accordance with Subsection (3)(b), at the following times:</u><br/>58&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  before dispensing an opioid; or</u><br/><hr>59&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  if the dispenser, in the dispenser's professional judgment, has a reasonable</u><br/>60&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>suspicion described in Subsection (2)(a)(iii).</u><br/>61&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(3) (a)  When a prescriber has reason or is required to access the database under</u><br/>62&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>Subsection (2)(a), the prescriber shall:</u><br/>63&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  review the available data regarding the patient for the 12-month period immediately</u><br/>64&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>preceding the patient encounter; and</u><br/>65&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  make an informed, current, professional decision regarding the appropriate</u><br/>66&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>quantities and frequency of dosage, consistent with generally recognized standards for the</u><br/>67&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>opioid being prescribed.</u><br/>68&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  When a dispenser has reason or is required to access the database under Subsection</u><br/>69&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)(b), the dispenser shall:</u><br/>70&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  review the available data regarding the patient for the 12-month period immediately</u><br/>71&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>preceding the patient encounter; and</u><br/>72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  if the dispenser's search of the database shows that the individual seeking an opioid</u><br/>73&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>may be obtaining opioids in quantities or with a frequency inconsistent with generally</u><br/>74&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>recognized standards for the opioid being dispensed, contact the prescriber to:</u><br/>75&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(A)  discuss the prescription and the database search results; and</u><br/>76&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(B)  obtain the prescriber's informed, current, and professional decision regarding</u><br/>77&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>whether the prescribed opioid is medically justified, notwithstanding the results of the database</u><br/>78&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>search.</u><br/>79&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(4) (a)  A prescriber is not strictly required to access the database under Subsection</u><br/>80&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(2)(a) if the prescriber reasonably determines that prescription of an opioid is nonetheless</u><br/>81&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>warranted when the prescriber prescribes an opioid:</u><br/>82&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  in a quantity that does not exceed an amount that is adequate for a single, seven-day</u><br/>83&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>treatment period;</u><br/>84&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  for direct administration to a patient in a hospital; or</u><br/>85&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(iii)  to a patient:</u><br/>86&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(A)  suffering from cancer or a condition associated with cancer;</u><br/>87&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(B)  suffering from a diagnosed terminal illness; or</u><br/>88&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(C)  in hospice care, thereby assuring reasonable and adequate direct supervision and</u><br/>89&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>administration.</u><br/><hr>90&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(b)  A dispenser is not required to access the database under Subsection (2)(b) if the</u><br/>91&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>dispenser dispenses an opioid:</u><br/>92&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(i)  in a quantity that does not exceed an amount that is adequate for a single, seven-day</u><br/>93&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>treatment period; or</u><br/>94&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<u>(ii)  for direct administration to a patient in a hospital.</u><br/><br/><hr style="width:90%; color: #333; text-align: right" /><br/><hr style="width:90%; color: #333; text-align: right" /><br/><br/><b>Legislative Review Note<br/>Office of Legislative Research and General Counsel</b>
</font>
</div>
</body>
</html>
